Bayer to Slash Its Dividend for 2023 to Reduce Debt
By Andrea Figueras
Bayer plans to slash its dividend and change its dividend policy in order to reduce debt, the company said Monday.
After a review of its capital allocation priorities, the German pharmaceutical and agricultural company said it will pay a 2023 dividend of 0.11 euros (12 U.S. cents) a share, compared with EUR2.40 for 2022.
"This proposal comes as the company faces a high level of debt, coupled with high interest rates and a challenging free cash flow situation," the company said.
The measure will be presented for shareholder vote at the annual meeting on April 26.
Bayer said it is implementing a new operating model that will include job cuts, aimed at making the company more agile and significantly improve its operational performance, as previously announced, it said.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
February 19, 2024 11:56 ET (16:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?